ALB and cancer: With the aim of having a new formulation drug delivery system with higher biostability, lower toxicity, higher tumor-targeting ability, and controlled drug release for efficient cancer treatments, here for the first time, the synergic delivery of 5FU and Cur by a folic-acid-decorated human serum albumin-coated GO nanocarrier (GO-ALB-FA) nanocarrier against folate-receptor overexpressing HT-29 cancer cells [31] has been evaluated.